Total Clarity Wealth Management, Inc. Guardant Health, Inc. Transaction History

Total Clarity Wealth Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$43.66 - $61.0 $10,915 - $15,250	-250 Reduced 5.88%	4,000 $215,000
Q2 2022 Jul 29, 2022	SELL	$28.82 - $77.35 $8,646 - $23,205	-300 Reduced 6.59%	4,250 $171,000
Q1 2022 Apr 29, 2022	SELL	$48.25 - $100.49 $4,825 - $10,049	-100 Reduced 2.15%	4,550 $301,000
Q4 2021 Feb 03, 2022	BUY	$88.71 - $120.43 $887 - $1,204	10 Added 0.22%	4,650 $465,000
Q2 2021 Jul 26, 2021	SELL	$109.77 - $165.68 $2,195 - $3,313	-20 Reduced 0.43%	4,640 $576,000
Q4 2020 Jan 20, 2021	BUY	$99.96 - $135.93 $11,995 - $16,311	120 Added 2.64%	4,660 $601,000
Q2 2020 Jul 15, 2020	SELL	$60.49 - $97.5 $9,073 - $14,625	-150 Reduced 3.2%	4,540 $368,000
Q4 2019 Feb 27, 2020	BUY	$59.49 - $82.78 $279,008 - $388,238	4,690 New	4,690 $366,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.97B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.